Penumbra Net Income 2014-2025 | PEN
Penumbra annual/quarterly net income history and growth rate from 2014 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Penumbra net income for the quarter ending March 31, 2025 was $0.039B, a 256.51% increase year-over-year.
- Penumbra net income for the twelve months ending March 31, 2025 was $0.042B, a 54.78% decline year-over-year.
- Penumbra annual net income for 2024 was $0.014B, a 84.59% decline from 2023.
- Penumbra annual net income for 2023 was $0.091B, a 4643.16% decline from 2022.
- Penumbra annual net income for 2022 was $-0.002B, a 137.89% decline from 2021.
| Penumbra Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $14 |
| 2023 | $91 |
| 2022 | $-2 |
| 2021 | $5 |
| 2020 | $-16 |
| 2019 | $48 |
| 2018 | $7 |
| 2017 | $5 |
| 2016 | $15 |
| 2015 | $1 |
| 2014 | $-1 |
| 2013 | $1 |
| Penumbra Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $39 |
| 2024-12-31 | $34 |
| 2024-09-30 | $30 |
| 2024-06-30 | $-60 |
| 2024-03-31 | $11 |
| 2023-12-31 | $54 |
| 2023-09-30 | $9 |
| 2023-06-30 | $19 |
| 2023-03-31 | $9 |
| 2022-12-31 | $4 |
| 2022-09-30 | $-2 |
| 2022-06-30 | $-4 |
| 2022-03-31 | $0 |
| 2021-12-31 | $-25 |
| 2021-09-30 | $9 |
| 2021-06-30 | $9 |
| 2021-03-31 | $12 |
| 2020-12-31 | $4 |
| 2020-09-30 | $-9 |
| 2020-06-30 | $-12 |
| 2020-03-31 | $1 |
| 2019-12-31 | $10 |
| 2019-09-30 | $11 |
| 2019-06-30 | $17 |
| 2019-03-31 | $11 |
| 2018-12-31 | $7 |
| 2018-09-30 | $-19 |
| 2018-06-30 | $13 |
| 2018-03-31 | $5 |
| 2017-12-31 | $9 |
| 2017-09-30 | $0 |
| 2017-06-30 | $-2 |
| 2017-03-31 | $-3 |
| 2016-12-31 | $-2 |
| 2016-09-30 | $12 |
| 2016-06-30 | $3 |
| 2016-03-31 | $2 |
| 2015-12-31 | $1 |
| 2015-09-30 | $0 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $1 |
| 2014-12-31 | |
| 2014-09-30 | $-1 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $10.887B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.696B | 87.47 |
| Thermo Fisher Scientific (TMO) | United States | $156.188B | 18.89 |
| Edwards Lifesciences (EW) | United States | $45.655B | 29.93 |
| Alcon (ALC) | Switzerland | $43.440B | 29.36 |
| IDEXX Laboratories (IDXX) | United States | $41.591B | 47.80 |
| DexCom (DXCM) | United States | $34.247B | 52.93 |
| IQVIA Holdings (IQV) | United States | $25.076B | 14.05 |
| Mettler-Toledo (MTD) | United States | $24.648B | 29.31 |
| STERIS (STE) | Ireland | $24.609B | 27.14 |
| Waters (WAT) | United States | $21.548B | 30.40 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.213B | 0.00 |
| Hologic (HOLX) | United States | $12.584B | 13.67 |
| Sysmex ADR (SSMXY) | Japan | $10.571B | 29.99 |
| Globus Medical (GMED) | United States | $8.473B | 19.87 |
| Masimo (MASI) | United States | $8.467B | 31.23 |
| Teleflex (TFX) | United States | $5.606B | 9.25 |
| Glaukos (GKOS) | United States | $5.571B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.243B | 22.23 |
| TransMedics (TMDX) | United States | $4.218B | 91.70 |
| PROCEPT BioRobotics (PRCT) | United States | $3.274B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.447B | 14.57 |
| Veracyte (VCYT) | United States | $2.256B | 31.66 |
| Elekta AB (EKTAY) | Sweden | $2.106B | 18.93 |
| Nihon Kohden (NHNKY) | Japan | $2.058B | 23.60 |
| Alphatec Holdings (ATEC) | United States | $1.896B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.567B | 0.00 |
| Artivion (AORT) | United States | $1.246B | 116.68 |
| Pulse Biosciences (PLSE) | United States | $1.148B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.035B | 5.50 |
| SiBone (SIBN) | United States | $0.840B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.687B | 0.00 |
| IRadimed (IRMD) | United States | $0.678B | 34.38 |
| RxSight (RXST) | United States | $0.675B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.627B | 13.70 |
| Delcath Systems (DCTH) | United States | $0.626B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.606B | 9.42 |
| NeuroPace (NPCE) | United States | $0.590B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.556B | 0.00 |
| AxoGen (AXGN) | United States | $0.527B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.468B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.467B | 12.43 |
| Treace Medical Concepts (TMCI) | United States | $0.421B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.386B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.358B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.306B | 0.00 |
| Neuronetics (STIM) | United States | $0.282B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.242B | 14.65 |
| Alpha Tau Medical (DRTS) | Israel | $0.229B | 0.00 |
| CVRx (CVRX) | United States | $0.182B | 0.00 |
| Accuray (ARAY) | United States | $0.179B | 0.00 |
| 908 Devices (MASS) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.169B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.141B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.140B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.138B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.122B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.099B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.095B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.084B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.00 |
| EDAP TMS S.A (EDAP) | France | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.056B | 17.08 |
| Hyperfine (HYPR) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Envoy Medical (COCH) | United States | $0.037B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.033B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 17.06 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |